Related Experiment Video
Updated: Dec 9, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
Monika Gawałko1,2, Agnieszka Kapłon-Cieślicka1, Mathias Hohl3
11st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Insights
This review examines the link between COVID-19 and atrial fibrillation (AF), the most common heart arrhythmia. It explores AF prevalence in SARS-CoV-2 patients and discusses management strategies.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic.
- Cardiovascular complications are increasingly recognized in COVID-19 patients.
- Atrial fibrillation (AF) is the most prevalent clinical arrhythmia, but its relationship with COVID-19 is not well understood.
Purpose of the Study:
- To review the current evidence on the prevalence and incidence of AF in patients with COVID-19.
- To discuss the clinical management of AF in the context of SARS-CoV-2 infection.
- To explore potential therapeutic strategies for managing AF in COVID-19 patients.
Main Methods:
- Systematic literature review of studies investigating AF in COVID-19 patients.
- Analysis of epidemiological data on AF prevalence and incidence.
- Discussion of clinical guidelines and emerging treatment options.
Main Results:
- Evidence suggests a potential association between COVID-19 and an increased risk of AF.
- Management of AF in COVID-19 patients requires careful consideration of anticoagulation and antiarrhythmic therapies.
- Further research is needed to elucidate the mechanisms underlying AF in COVID-19 and optimize treatment.
Conclusions:
- COVID-19 may influence the occurrence and management of atrial fibrillation.
- Integrated care approaches are essential for patients with both conditions.
- Understanding the interplay between SARS-CoV-2 and AF is crucial for improving patient outcomes.
Abstract:
Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Dysrhythmias II: Classification of Tachyarrhythmias